D. Decoo

Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomised, phase 3 study

Ludwig Kappos, Amit Bar‐Or, Bruce Cree et al. · The Lancet · 2018 · 896 citations

Neurological Disorder, Clinical Neurology, Clinical Trials +9

Accurate differentiation of parkinsonism and essential tremor using visual assessment of [123I]-FP-CIT SPECT imaging: The [123I]-FP-CIT study group

Hani T. S. Benamer, J. Patterson, Donald G. Grosset et al. · Movement Disorders · 2000 · 701 citations

Assessment of Neuroinflammation and Microglial Activation in Alzheimer’s Disease with Radiolabelled PK11195 and Single Photon Emission Computed Tomography

Jan Versijpt, Filip Dumont, Koen J. van Laere et al. · European Neurology · 2003 · 149 citations

Characterizing absolute lymphocyte count profiles in dimethyl fumarate–treated patients with MS

Robert J. Fox, Andrew Chan, Ralf Gold et al. · Neurology Clinical Practice · 2016 · 104 citations · Full text

Imaging of the 5-HT2A system: age-, gender-, and Alzheimer’s disease-related findings

Jan Versijpt, Koen J. van Laere, F. Dumont et al. · Neurobiology of Aging · 2003 · 102 citations

Neuroimaging Biomarkers, Neurodegenerative Diseases, Alzheimer's Disease +11